Be Aware Otezla May Be Safer Than Methotrexate for Plaque Psoriasis

March 2015

You'll see two new treatment options for moderate to severe plaque psoriasis, Otezla (apremilast) and Cosentyx (secukinumab).

About 20% of psoriasis patients need systemic meds added to topicals.

Be aware of the extra interactions, side effects, and monitoring.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote